Article Details
Retrieved on: 2021-07-01 02:49:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NS) said on Thursday it has applied for emergency use approval of its three-dose COVID-19 vaccine that showed efficacy of 66.6% in an interim study ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here